Eterna Therapeutics (ERNA) - 2020 Q4 - Annual Report
Eterna Therapeutics (ERNA)2021-03-11 22:07UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2020 Commission File Number 1-11460 | --- | --- | --- | --- | |---------------------------------------|--------------------------------------------|--------------------------|-----------------------------------| | | NTN (Exact name of registrant as | Buzztime, Inc. specified | in its charter) | | Delaware ...